Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the Transatlantic Australasian RPS Working Group

…, E Stoeckle, JB Park, M Albertsmeier, C Nessim… - Annals of surgical …, 2021 - Springer
Background Retroperitoneal soft tissue sarcomas comprise a heterogeneous group of rare
tumors of mesenchymal origin that include several well-defined histologic subtypes. In 2015, …

Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG

…, E Stoeckle, A De Paoli, VG Pillarisetty, C Nessim… - Clinical cancer …, 2019 - AACR
Purpose: The role of surgery for first relapse locally recurrent retroperitoneal sarcoma (RPS-LR1)
is uncertain. We report outcomes of the largest RPS-LR1 series and propose a new …

[HTML][HTML] Immunotherapy for sarcomas: new frontiers and unveiled opportunities

…, S Cortés-Kaplan, J Werier, C Nessim… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Sarcomas are a rare malignancy of mesenchymal tissues, comprizing a plethora of unique
subtypes, with more than 60 types. The sheer heterogeneity of disease phenotype makes this …

Clinical outcomes and risk stratification of early-stage melanoma micrometastases from an international multicenter study: implications for the management of …

…, AP Snelling, MJ Carr, C Nessim… - Journal of Clinical …, 2022 - ingentaconnect.com
PURPOSE Indications for offering adjuvant systemic therapy for patients with early-stage
melanomas with low disease burden sentinel node (SN) micrometastases, namely, American …

[HTML][HTML] Retroperitoneal sarcoma care in 2021

E Schmitz, C Nessim - Cancers, 2022 - mdpi.com
Simple Summary Soft-tissue sarcomas are exceedingly rare, accounting for <1% of all adult
malignancies. Sarcomatous tumors are located within the retroperitoneum in <10% of cases. …

Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states

…, J Dimitroulakos, A Arnaout, C Nessim… - Molecular …, 2018 - Wiley Online Library
Triple‐negative breast cancer ( TNBC ), the most refractory subtype of breast cancer to current
treatments, accounts disproportionately for the majority of breast cancer‐related deaths. …

Radioactive seed localization versus wire-guided localization for nonpalpable breast cancer: a cost and operating room efficiency analysis

…, AM Ibrahim, A Arnaout, D Gravel, C Nessim - Annals of surgical …, 2017 - Springer
Background This study aimed to compare the cost and resource use between our first-year
experience using breast-conserving surgery (BCS) with radioactive seed localization (RSL) …

Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal …

…, CP Raut, M Fairweather, JM Farma, C Nessim… - Cancer, 2021 - Wiley Online Library
Background In patients with retroperitoneal sarcoma (RPS), the incidence of recurrence after
surgery remains high. Novel treatment approaches are needed. This retrospective study …

Landmark series: a review of landmark studies in the treatment of primary localized retroperitoneal sarcoma

M Delisle, D Gyorki, S Bonvalot, C Nessim - Annals of Surgical Oncology, 2022 - Springer
Primary localized retroperitoneal soft tissue sarcomas (RPS) have shorter survival than other
soft tissue sarcoma sites owing to higher local recurrence rates associated with histologic …

Early and late complications of percutaneous core needle biopsy of retroperitoneal tumors at two tertiary sarcoma centers

…, B Purgina, K Ambacher, C Nessim… - Annals of Surgical …, 2019 - Springer
Background Concern persists regarding percutaneous core needle biopsy (CNB) of a
potentially malignant lesion of the retroperitoneum due to the perceived risk of immediate …